Artelo Biosciences, Inc. (ARTL) vs Creative Medical Technology Holdings, Inc. (CELZ)
A side-by-side comparison of Artelo Biosciences, Inc. and Creative Medical Technology Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTL
Artelo Biosciences, Inc.
$3.39HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
CELZ
Creative Medical Technology Holdings, Inc.
$0.90HealthcareDelayed quote: Oct 6, 2026, 3:33 PM EDT
Total return — ARTL vs CELZ
growth of $100 · dividends reinvested · last 7yARTL -99.9% (-63.1%/yr)CELZ -100.0% (-68.9%/yr)ARTL compounded faster over this window
ARTL CELZ
ARTL vs CELZ: by the numbers
- •CELZ is the larger company ($2M vs $1M market cap).
- •Both run net losses; ARTL's is the smaller (0.00% vs -201355.37% net margin).
Metrics side by side
Valuation
| Metric | ARTL | CELZ |
|---|---|---|
| P/S ratio | N/A | 773.60 |
| P/B ratio | 0.26 | 0.27 |
Profitability
| Metric | ARTL | CELZ |
|---|---|---|
| Gross margin | 0.00% | 63.43% |
| Operating margin | 0.00% | -102380.23% |
| Net margin | 0.00% | -201355.37% |
| ROE | -253.57% | -69.79% |
| ROIC | -219.36% | -71.90% |
Growth (annualized)
| Metric | ARTL | CELZ |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -50.85% |
| Total return CAGR (5Y) | -64.27% | -57.96% |
Frequently asked
- How have ARTL and CELZ total returns compared?
- Over the past 5 years, ARTL delivered -64.27% and CELZ delivered -57.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.